Literature DB >> 2364361

Lymphomas in dogs. A morphologic, immunologic, and clinical study.

P G Greenlee1, D A Filippa, F W Quimby, A K Patnaik, S E Calvano, R E Matus, M Kimmel, A I Hurvitz, P H Lieberman.   

Abstract

One hundred seventy-six canine lymphomas were classified morphologically using four of the major human lymphoma classification schemes (Rappaport, Lukes-Collins, Kiel, and the Working Formulation). All 176 dogs received the same chemotherapeutic protocol. Sixty-two of these lymphomas had their immunophenotypes established by examination of cell surface markers by automated cytofluorography. Several different morphologic types of canine lymphoma were identified and these were comparable to morphologic categories in human classification schemes. Follicular and low grade lymphomas were rare. The two most common morphologic types were diffuse large cell (centroblastic) and immunoblastic. The Kiel classification appeared to be the most useful human scheme for classifying the canine lymphomas. Cytofluorographic analysis was generally straightforward, and 60 of the 62 lymphomas were placed into one of three immunophenotypic categories: 27 pan-T(LQ1)+SIg+, 21 pan-T(LQ1)-SIg+, and 12 pan-T(LQ1)+SIg-. Two of the lymphomas could not be characterized immunologically because a pre-existing or reactive non-neoplastic population of lymphocytes made interpretation of single cell suspension analysis difficult. The authors identified correlations between morphology and survival and disease-free remission; dogs with high-grade tumors generally survived the longest and had the longest remissions. No correlations were identified between high concentrations of serum lactate dehydrogenase, age, sex, or stage of disease, and morphology, immunophenotype, remission, or survival times. A significant correlation between clinical illness and survival time was documented. The median age of the dogs was nine years, no significant effect of sex on prevalence was observed, and some breeds were significantly overrepresented. Significant morphologic-immunophenotypic correlations included shorter remission and survival times for T-cell tumors than B-cell tumors, and a highly significant correlation between the pan-T(LQ1)+SIg-"T cell" phenotype and hypercalcemia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2364361     DOI: 10.1002/1097-0142(19900801)66:3<480::aid-cncr2820660314>3.0.co;2-x

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  27 in total

1.  Diagnostic and prognostic value of serum lactate dehydrogenase (LDH) and LDH isoenzymes in canine lymphoma.

Authors:  R Zanatta; O Abate; A D'Angelo; B Miniscalco; A Mannelli
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

2.  Oxidative stress in dogs with multicentric lymphoma: Effect of chemotherapy on oxidative and antioxidant biomarkers.

Authors:  Nathieli B Bottari; Thiago D Munhoz; Vanessa D Torbitz; Alexandre A Tonin; Letícia A Anai; Lívia M S Semolin; Paulo C Jark; Yãnaí S Bollick; Rafael N Moresco; Raqueli T França; Sonia T A Lopes; Lenita M Stefani; Mirela Tinucci-Costa; Aleksandro S Da Silva
Journal:  Redox Rep       Date:  2015-08-14       Impact factor: 4.412

3.  Translational repression of p53 by RNPC1, a p53 target overexpressed in lymphomas.

Authors:  Jin Zhang; Seong-Jun Cho; Limin Shu; Wensheng Yan; Teri Guerrero; Michael Kent; Katherine Skorupski; Hongwu Chen; Xinbin Chen
Journal:  Genes Dev       Date:  2011-07-15       Impact factor: 11.361

4.  Factors associated with long-term survival in dogs undergoing liver lobectomy as treatment for liver tumors.

Authors:  Jessica R Kinsey; Stephen D Gilson; Joe Hauptman; Steve J Mehler; Lauren R May
Journal:  Can Vet J       Date:  2015-06       Impact factor: 1.008

Review 5.  Fetal Microchimerism in Cancer Protection and Promotion: Current Understanding in Dogs and the Implications for Human Health.

Authors:  Jeffrey N Bryan
Journal:  AAPS J       Date:  2015-02-19       Impact factor: 4.009

6.  Molecular cytogenetic analysis of a novel high-grade canine T-lymphoblastic lymphoma demonstrating co-expression of CD3 and CD79a cell markers.

Authors:  R Thomas; K C Smith; R Gould; S M Gower; M M Binns; M Breen
Journal:  Chromosome Res       Date:  2001       Impact factor: 5.239

7.  Evaluation of an actinomycin-D-containing combination chemotherapy protocol with extended maintenance therapy for canine lymphoma.

Authors:  Cecile T Siedlecki; Philip H Kass; Martin J Jakubiak; Gillian Dank; Jarred Lyons; Michael S Kent
Journal:  Can Vet J       Date:  2006-01       Impact factor: 1.008

8.  Hormonal and sex impact on the epidemiology of canine lymphoma.

Authors:  J Armando Villamil; Carolyn J Henry; Allen W Hahn; Jeffrey N Bryan; Jeff W Tyler; Charles W Caldwell
Journal:  J Cancer Epidemiol       Date:  2010-03-14

9.  Canine cutaneous epitheliotropic lymphoma (mycosis fungoides) is a proliferative disorder of CD8+ T cells.

Authors:  P F Moore; T Olivry; D Naydan
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

10.  Authentication of primordial characteristics of the CLBL-1 cell line prove the integrity of a canine B-cell lymphoma in a murine in vivo model.

Authors:  Barbara C Rütgen; Saskia Willenbrock; Nicola Reimann-Berg; Ingrid Walter; Andrea Fuchs-Baumgartinger; Siegfried Wagner; Boris Kovacic; Sabine E Essler; Ilse Schwendenwein; Ingo Nolte; Armin Saalmüller; Hugo Murua Escobar
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.